Allergic bronchopulmonary aspergillosis successfully treated with benralizumab

Allergic bronchopulmonary aspergillosis (ABPA) is an immunological pulmonary disease characterized by hypersensitivity to Aspergillus fumigatus, manifesting as uncontrolled asthma, eosinophilia, and lung infiltrations. Once expressed, ABPA does not remit completely. Many patients with ABPA require long-term treatment. Systemic corticosteroids (SCSs) and itraconazole are the current treatment for ABPA,1 and the responses to SCSs and itraconazole...